In breast cancer, SIRT6 can enhance the expression and activity of pyruvate dehydrogenase (PDH), thereby enhancing oxidative phosphorylation in breast cancer cells and promoting the occurrence of breast tumors in mice (103). Here, PDP1 is linked to breast cancer.